Ignite Creation Date:
2025-12-17 @ 2:50 PM
Ignite Modification Date:
2025-12-23 @ 4:53 PM
Study NCT ID:
NCT01419795
Status:
TERMINATED
Last Update Posted:
2017-07-27
First Post:
2011-08-15
Is Possible Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-05
Start Date Type:
None
Primary Completion Date:
2013-09
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2011-08-15
First Submit QC Date:
None
Study First Post Date:
2011-08-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-01-31
Results First Submit QC Date:
None
Results First Post Date:
2017-03-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-07-24
Last Update Post Date:
2017-07-27
Last Update Post Date Type:
ACTUAL